Apogem Capital’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,332
| Closed | -$804K | – | 63 |
|
|
2022
Q3 | $804K | Sell |
9,332
-61
| -0.6% | -$5.26K | 0.8% | 34 |
|
|
2022
Q2 | $777K | Buy |
9,393
+7,191
| +327% | +$595K | 0.7% | 40 |
|
|
2022
Q1 | $366K | Sell |
2,202
-501
| -19% | -$83.3K | 0.25% | 114 |
|
|
2021
Q4 | $452K | Sell |
2,703
-2,132
| -44% | -$357K | 0.3% | 101 |
|
|
2021
Q3 | $418K | Sell |
4,835
-3,052
| -39% | -$264K | 0.27% | 121 |
|
|
2021
Q2 | $428K | Buy |
7,887
+2,120
| +37% | +$115K | 0.27% | 115 |
|
|
2021
Q1 | $344K | Buy |
+5,767
| New | +$344K | 0.23% | 126 |
|